Literature DB >> 24308834

Immunoglobulin class switch recombination deficiency type 1 or CD40 ligand deficiency: from bedside to bench and back again.

Armin Hirbod-Mobarakeh1, Asghar Aghamohammadi, Nima Rezaei.   

Abstract

The immunoglobulin class switch recombination deficiency or hyper-IgM syndrome is characterized by normal or elevated serum IgM and low serum levels of other immunoglobulins. Since the first reported patient with hyper-IgM, more than 200 patients with this phenotype resulted from CD40 ligand deficiency have been reported. However, in addition to this common finding, they presented with different manifestations like opportunistic infections, autoimmunity and malignancies each of them are worth a detailed look. In this review, we will focus on different underlying mechanisms of these presentations to review what we have learned from our patients. In the end, we will discuss different treatment options available for these patients using this knowledge.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24308834     DOI: 10.1586/1744666X.2014.864554

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  11 in total

1.  A novel CD40LG deletion causes the hyper-IgM syndrome with normal CD40L expression in a 6-month-old child.

Authors:  Gabriela López-Herrera; José Luis Maravillas-Montero; Alexander Vargas-Hernández; Laura Berrón-Ruíz; Emmanuel Ramírez-Sánchez; Marco Antonio Yamazaki-Nakashimada; Francisco Javier Espinosa-Rosales; Leopoldo Santos-Argumedo
Journal:  Immunol Res       Date:  2015-05       Impact factor: 2.829

2.  Respiratory Complications in Patients with Hyper IgM Syndrome.

Authors:  Bobak Moazzami; Reza Yazdani; Gholamreza Azizi; Fatemeh Kiaei; Mitra Tafakori; Mohammadreza Modaresi; Rohola Shirzadi; Seyed Alireza Mahdaviani; Mahsa Sohani; Hassan Abolhassani; Asghar Aghamohammadi
Journal:  J Clin Immunol       Date:  2019-06-11       Impact factor: 8.317

3.  Lung Vascular Remodeling, Cardiac Hypertrophy, and Inflammatory Cytokines in SHIVnef-Infected Macaques.

Authors:  Sharilyn Almodovar; Jessica Swanson; Luis D Giavedoni; Sreetharan Kanthaswamy; Carlin S Long; Norbert F Voelkel; Michael G Edwards; Joy M Folkvord; Elizabeth Connick; Susan V Westmoreland; Paul A Luciw; Sonia C Flores
Journal:  Viral Immunol       Date:  2017-12-19       Impact factor: 2.257

4.  IL-21/anti-Tim1/CD40 ligand promotes B10 activity in vitro and alleviates bone loss in experimental periodontitis in vivo.

Authors:  Yang Hu; Pei Yu; Xinbo Yu; Xingxue Hu; Toshihisa Kawai; Xiaozhe Han
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-06-03       Impact factor: 5.187

Review 5.  Predispositions to Lymphoma: A Practical Review for Genetic Counselors.

Authors:  Morgan Similuk; V Koneti Rao; Jane Churpek; Michael Lenardo
Journal:  J Genet Couns       Date:  2016-06-06       Impact factor: 2.537

Review 6.  Immune dysregulation in patients with RAG deficiency and other forms of combined immune deficiency.

Authors:  Ottavia M Delmonte; Anna Villa; Luigi D Notarangelo
Journal:  Blood       Date:  2020-02-27       Impact factor: 22.113

7.  Lymphocytic Interstitial Pneumonitis: An Unusual Presentation of X-Linked Hyper Ig M Syndrome.

Authors:  Mohsen Reisi; Gholamreza Azizi; Tooba Momen; Hassan Abolhassani; Asghar Aghamohammadi
Journal:  Iran J Pediatr       Date:  2016-03-05       Impact factor: 0.364

8.  First Case of CD40LG Deficiency in Ecuador, Diagnosed after Whole Exome Sequencing in a Patient with Severe Cutaneous Histoplasmosis.

Authors:  Luis Alberto Pedroza; Nina Guerrero; Asbjørg Stray-Pedersen; Cristina Tafur; Roque Macias; Greta Muñoz; Zeynep Coban Akdemir; Shalini N Jhangiani; Levi B Watkin; Ivan K Chinn; James R Lupski; Jordan S Orange
Journal:  Front Pediatr       Date:  2017-02-10       Impact factor: 3.418

9.  A Novel de Novo Mutation in the CD40 Ligand Gene in a Patient With a Mild X-Linked Hyper-IgM Phenotype Initially Diagnosed as CVID: New Aspects of Old Diseases.

Authors:  Tábata T França; Luiz F B Leite; Tiago A Maximo; Christiane G Lambert; Nuria B Zurro; Wilma C N Forte; Antonio Condino-Neto
Journal:  Front Pediatr       Date:  2018-05-04       Impact factor: 3.418

10.  Hyper IgM Syndrome: a Report from the USIDNET Registry.

Authors:  Emily A Leven; Patrick Maffucci; Hans D Ochs; Paul R Scholl; Rebecca H Buckley; Ramsay L Fuleihan; Raif S Geha; Coleen K Cunningham; Francisco A Bonilla; Mary Ellen Conley; Ronald M Ferdman; Vivian Hernandez-Trujillo; Jennifer M Puck; Kathleen Sullivan; Elizabeth A Secord; Manish Ramesh; Charlotte Cunningham-Rundles
Journal:  J Clin Immunol       Date:  2016-05-17       Impact factor: 8.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.